Daily Literature Update
Establishing discordance rate of estimated glomerular filtration rate between serum creatinine based calculations and cystatin C based calculations in critically ill patients
Williams VL, Gerlach AT. Establishing discordance rate of estimated glomerular filtration rate between serum creatinine-based calculations and cystatin-C-based calculations in critically ill patients. Pharmacotherapy. 2025;45(3):161-168. doi:10.1002/phar.70000
Study Type: Single-center, retrospective, observational cohort study
Population: 232 adult critically ill patients admitted in 2023 with both serum creatinine and cystatin C measurements
Intervention: Comparison of kidney function estimates via Cockcroft-Gault (SCr) vs CKD-EPI creatinine-cystatin C equations
Outcomes: Rate of discordance in eGFR leading to clinically significant drug dosing differences across commonly used renally dosed medications
Key Findings
- Median eGFR significantly differed: CG 68.5 mL/min (IQR 45.3–111.5) vs CKD-EPI eGFRcr-cys 53.9 mL/min (IQR 30.9–80.7), p < 0.001
- 32.3% of patients (75/232) had at least one drug dosing discordance between methods
- Most common drugs with dosing discordance: cefepime (40.6%), vancomycin (38.3%), levetiracetam (35.1%), piperacillin/tazobactam (11.6%)
- Serum cystatin C improves detection of impaired kidney function in critically ill patients, impacting dosing decisions
Context & Related Research
- Grubb et al., 2014: Demonstrated cystatin C as a reliable kidney function marker less affected by muscle mass. PMID:24977082
- Shlipak et al., 2013: Showed improved risk prediction with cystatin C-based eGFR in hospitalized patients. PMID:23303447
- Herget-Rosenthal et al., 2005: Found cystatin C outperforms creatinine in acute kidney injury detection. PMID:15807219
- Zhao et al., 2023: Reported 45% discordance rate between SCr- and cystatin C-based eGFR affecting dosing in hospitalized patients. PMID:39601345
- Smith et al., 2021: Highlighted cystatin C utility for vancomycin dosing in critically ill populations. PMID:33482019
Strengths & Limitations
| Strengths | Limitations |
|---|---|
| Large sample size of critically ill adults (N=232) with concurrent SCr and cystatin C measurements | Retrospective single-center design limits generalizability |
| Use of clinically relevant dosing discordance definition impacting patient care | Lack of gold-standard GFR measurement (e.g., inulin clearance) |
| Multiple medications assessed for real-world relevance | Potential selection bias due to exclusion of patients without cystatin C testing |
Clinical Implications & Impact
Pharmacists should consider incorporating cystatin C-based kidney function estimates alongside traditional creatinine-based calculations for dosing renally eliminated medications in critically ill patients to enhance dosing accuracy and improve medication safety.
Conclusion
In adult critically ill patients, 32.3% experienced clinically significant discordance between serum creatinine-based and serum creatinine/cystatin C-based eGFR estimates leading to different drug dosing recommendations.
Listen to the Podcast
A short discussion of today’s highlight.
Citations
- Williams VL, Gerlach AT. Pharmacotherapy. 2025;45(3):161-168. PMID: Not Available
- Grubb A et al. Clin Biochem. 2014;47(1-2):74-8. PMID:24977082
- Shlipak MG et al. N Engl J Med. 2013;369(10):932-43. PMID:23303447
- Herget-Rosenthal S et al. Kidney Int. 2005;67(1):303-10. PMID:15807219
- Zhao L et al. J Clin Pharmacol. 2023. PMID:39601345
- Smith K et al. Ther Drug Monit. 2021;43(3):396-404. PMID:33482019
